Aprea Therapeutics, Inc. (APRE) vs Curanex Pharmaceuticals Inc Common Stock (CURX)
A side-by-side comparison of Aprea Therapeutics, Inc. and Curanex Pharmaceuticals Inc Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APRE
Aprea Therapeutics, Inc.
$0.67HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT
CURX
Curanex Pharmaceuticals Inc Common Stock
$5.06HealthcareDelayed quote: Oct 6, 2026, 9:50 AM EDT
Total return — APRE vs CURX
growth of $100 · dividends reinvested · last 1yAPRE -57.2% (-57.2%/yr)CURX -93.8% (-93.8%/yr)APRE compounded faster over this window
Log scale — wide-divergence pair
APRE CURX
APRE vs CURX: by the numbers
- •APRE is the larger company ($8M vs $7M market cap).
Metrics side by side
Valuation
| Metric | APRE | CURX |
|---|---|---|
| P/B ratio | 0.21 | 1.50 |
Profitability
| Metric | APRE | CURX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -31.99% | -218.65% |
| ROIC | -33.73% | -208.39% |
Growth (annualized)
| Metric | APRE | CURX |
|---|---|---|
| Total return CAGR (5Y) | -63.30% | N/A |
Go deeper
Dig into the metrics
Aprea Therapeutics ROECuranex Pharmaceuticals Inc Common Stock ROEAprea Therapeutics operating marginCuranex Pharmaceuticals Inc Common Stock operating marginAprea Therapeutics revenue growthCuranex Pharmaceuticals Inc Common Stock revenue growthAprea Therapeutics free cash flowCuranex Pharmaceuticals Inc Common Stock free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.